RxSight, Inc.
RXST · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$27 | -$49 | -$67 | -$49 |
| Dep. & Amort. | $4 | $4 | $4 | $4 |
| Deferred Tax | $0 | $0 | $0 | -$5 |
| Stock-Based Comp. | $25 | $16 | $11 | $8 |
| Change in WC | -$9 | -$9 | -$7 | -$3 |
| Other Non-Cash | -$9 | -$4 | -$0 | $0 |
| Operating Cash Flow | -$17 | -$42 | -$59 | -$45 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5 | -$5 | -$2 | -$2 |
| Net Acquisitions | $0 | $17 | -$42 | $80 |
| Inv. Purchases | -$337 | -$272 | -$213 | -$160 |
| Inv. Sales/Matur. | $243 | $255 | $255 | $80 |
| Other Inv. Act. | $0 | -$17 | $42 | -$80 |
| Investing Cash Flow | -$99 | -$22 | $40 | -$82 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$40 | -$0 | $15 |
| Stock Issued | $129 | $106 | $8 | $121 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$6 | -$4 | -$1 | $1 |
| Financing Cash Flow | $123 | $62 | $6 | $137 |
| Forex Effect | -$0 | $0 | -$0 | -$0 |
| Net Chg. in Cash | $7 | -$2 | -$13 | $11 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $10 | $13 | $25 | $14 |
| End Cash | $17 | $10 | $13 | $25 |
| Free Cash Flow | -$22 | -$46 | -$61 | -$47 |